Skip to content

Maintenance of Multivitamin Supplements After Sleeve Gastrectomy

Maintenance of Multivitamin Supplements After Sleeve Gastrectomy

Status
Completed
Phases
Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02620137
Enrollment
80
Registered
2015-12-02
Start date
2013-01-31
Completion date
2015-11-30
Last updated
2015-12-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Iron Deficiency Anemia

Brief summary

A prospective randomized study of patients undergoing a laparoscopic sleeve gastrectomy was performed. Patients were randomized into 2 groups: those patients receiving the multivitamin supplement during 3 months (Group 1), and those receiving the supplement during 12 months (Group 2). Laboratory data were recorded: vitamins and oligoelements at 3, 6 and 12 months after surgery.

Detailed description

A prospective randomized study of patients undergoing a laparoscopic sleeve gastrectomy was performed. Patients were randomized into 2 groups: those patients receiving the multivitamin supplement (Multicentrum, Pfizer, 1 tablet/day) during 3 months (Group 1), and those receiving the supplement during 12 months (Group 2). Laboratory data were recorded: vitamins (D, B12 and folic acid) and oligoelements (calcium, iron, phosphorus, magnesium and zinc) at 3, 6 and 12 months after surgery.

Interventions

DRUGMulticentrum® (Pfizer, Spain) 3 months

The multivitamin supplement (Multicentrum® (Pfizer, Spain) 1 tablet/day) will be maintained during 3 months

DRUGMulticentrum® (Pfizer, Spain) 12 months

The multivitamin supplement (Multicentrum® (Pfizer, Spain) 1 tablet/day) will be maintained during 12 months

Sponsors

Hospital General Universitario Elche
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* patients undergoing laparoscopic sleeve gastrectomy * BMI \>40 Kg/m2 * BMI \> 35 Kg/m2 with the presence of comorbidities associated to obesity

Exclusion criteria

* documented gastroesophageal reflux * patients with uncontrolled psychiatric disorders * active infections or malignancies * any other concomitant pathology considered as a contraindication for bariatric surgery.

Design outcomes

Primary

MeasureTime frameDescription
Iron serum levels12 monthsIron serum levels will be investigated in blood samples 12 months after surgery

Secondary

MeasureTime frameDescription
Calcium serum levels12 monthsCalcium serum levels will be investigated in blood samples 12 months after surgery
Vitamin B12 serum levels12 monthsVitamin B12 serum levels will be investigated in blood samples 12 months after surgery
Folic acid serum levels12 monthsVitamin B12 serum levels will be investigated in blood samples 12 months after surgery

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 12, 2026